Donor Specific Regulation (DSR) Guided Tacrolimus Withdrawal to Myfortic Monotherapy in Liver Transplantation.
Phase of Trial: Phase III
Latest Information Update: 20 Jun 2014
At a glance
- Drugs Mycophenolate sodium (Primary) ; Tacrolimus
- Indications Liver transplant rejection
- Focus Adverse reactions
- 25 Jun 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 25 Jun 2012 Actual patient number is 10 according to ClinicalTrials.gov.
- 25 Jun 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.